BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33236530)

  • 1. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2.
    Li XL; Li SZ; Wu CX; Xing XH
    Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer.
    Chen J; Yu Y; Li H; Hu Q; Chen X; He Y; Xue C; Ren F; Ren Z; Li J; Liu L; Duan Z; Cui G; Sun R
    Mol Cancer; 2019 Mar; 18(1):33. PubMed ID: 30825877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.
    Ye YY; Mei JW; Xiang SS; Li HF; Ma Q; Song XL; Wang Z; Zhang YC; Liu YC; Jin YP; Hu YP; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu YB
    Cell Death Dis; 2018 Mar; 9(3):410. PubMed ID: 29540696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
    He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
    Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
    Zhang X; Zhang L; Chen M; Liu D
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.
    Liu XF; Wang K; Du HC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
    Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
    Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of LINC01694 inhibits growth of gallbladder cancer cells via miR-340-5p/Sox4.
    Liu L; Yan Y; Zhang G; Chen C; Shen W; Xing P
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32270853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
    Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
    Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
    Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
    Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
    Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma.
    He Y; Chen X; Yu Y; Li J; Hu Q; Xue C; Chen J; Shen S; Luo Y; Ren F; Li C; Bao J; Yan J; Qian G; Ren Z; Sun R; Cui G
    Mol Carcinog; 2018 Jun; 57(6):772-783. PubMed ID: 29569755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7.
    Hu X; Zhang J; Bu J; Yang K; Xu S; Pan M; Xiang D; Chen W
    Bioengineered; 2022 Apr; 13(4):10691-10706. PubMed ID: 35443866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing SNHG1 Suppresses Viability, Proliferation and Invasion of Gallbladder Carcinoma Cells via Targeting miR-194-5p.
    Lu X; Hu K; Tan Q; Zhao K
    Ann Clin Lab Sci; 2022 Sep; 52(5):707-720. PubMed ID: 36261179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.
    Cai J; Xu L; Cai Z; Wang J; Zhou B; Hu H
    Mol Med Rep; 2015 Jul; 12(1):1549-55. PubMed ID: 25760482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.